100% confidential Case Evaluations
Answer a few basic questions to get started
Receive a confidential case evaluation
Have an individual claim filed for compensation
Billions in profits made on unsafe Medication
How does Zantac® (aka ranitidine®) cause liver cancer?
Glaxo Holdings Ltd® (aka GSK® or GlaxoSmithKline®) created and sold Zantac® beginning in 1983 to reduce excess acid produced in stomach cells.
Initially approved only for short-term use by the Federal Drug Administration (FDA) due to its potential to cause cancer in long-term use, Zantac® was then marketed for long-term use without appropriate warnings.
Since Zantac® (aka ranitidine®) contains dangerously high levels of a potentially dangerous chemical called N-nitrosodimethylamine (NDMA), it has potentially been linked to several types of lifelong cancers–namely liver cancer.
Shield Legal Network believes that liver cancer victims should get the justice and compensation they deserve by addressing the makers of Zantac® (aka ranitidine®) in a court of law.
Zantac® and Liver Cancer in the News
2021
Researchers found those who used ranitidine regularly were 1.9 times more likely to have liver cancer.
2020
On February 6, 2020, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Zantac liver cancer lawsuits into the Southern District of Florida.
2019
Though many companies recalled their ranitidine products in the latter part of 2019, the FDA did not require an overall recall of the medication until April 1, 2020.